Versant Venture Capital V, L.P. 13D and 13G filings for Turnstone Biologics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-12 4:44 pm Sale | 2025-08-08 | 13D | TURNSTONE BIOLOGICS CORP COM TSBX | Versant Venture Capital V, L.P. | 0 0.000% | -2,899,216 (Position Closed) | Filing |
| 2023-08-03 4:41 pm Purchase | 2023-07-25 | 13D | TURNSTONE BIOLOGICS CORP COM TSBX | Versant Venture Capital V, L.P. | 2,899,216 12.500% | 2,899,216 (New Position) | Filing |